Gregory D Davis insider trades: Sangamo Therapeutics (SGMO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gregory reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | SGMO | ↓ Sell | 69,827 | $0.25 | $18K | Direct | Apr 23, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGMO insiders
Open-market trades in the last 12 months
About Gregory D Davis's insider trades
Gregory D Davis is Head of Research & Technology at Sangamo Therapeutics (SGMO). Since Apr 22, 2026, Gregory has reported no open-market purchases and 1 sale worth $18K on SEC Form 4. In the last 12 months: 1 sale ($18K).
Their filings also include shares withheld for taxes (11 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.